Aktiesnakken — Januar 2011
-
-
vent til salgstallene!
-
den R&D dag var ikke det vi havde brug for. Men Genmab vil ikke lytte. Og de gider ikke kigge på kursen heller
-
Jep, 62,- fra den absolutte bund...
-
Upside er dog klart mere end de 62,- ;0)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind